Discover 998 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 998
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
for
Lymphoma, Sarcoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07058064
Recruiting
A Study of TopSpin360 Training Device
for
Healthy
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 21
Code: NCT06052553
Recruiting
Subcortical Arousal in Perceptual Awareness
for
Epilepsy
Location: Rochester MN, Kansas City KS, Nashville TN, Houston TX,
Sponsor: Yale University
Sex: All
Age: 13+
Code: NCT06934356
Recruiting
Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI
for
Spinal Cord Injuries
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70+
Code: NCT07210437
Recruiting
Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury
for
Spinal Cord Injuries
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 50
Code: NCT07210411
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Rochester MN, Indianapolis IN, Wichita KS,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07196722
Phase2, Phase3, Recruiting
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
for
Breast Carcinoma
Location: Rochester MN, Jacksonville FL
Sponsor: Mayo Clinic
Sex: Female
Age: 18 - 70+
Code: NCT07207564
Recruiting
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
for
Proliferative Diabetic Retinopathy (PDR)
Location: Rochester MN, Saint Louis Park MN, West Des Moines IA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT06790784
Phase3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)